These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1593 related items for PubMed ID: 18617466

  • 1. [Etiology, diagnostics and therapy of hyponatremias].
    Laczi F.
    Orv Hetil; 2008 Jul 20; 149(29):1347-54. PubMed ID: 18617466
    [Abstract] [Full Text] [Related]

  • 2. [Vasopressin receptor antagonists and heart failure].
    Haass M.
    Ther Umsch; 2009 Nov 20; 66(11):735-40. PubMed ID: 19885790
    [Abstract] [Full Text] [Related]

  • 3. A novel vasopressin dual V1A/V2 receptor antagonist, conivaptan hydrochloride, improves hyponatremia in rats with syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
    Wada K, Matsukawa U, Fujimori A, Arai Y, Sudoh K, Sasamata M, Miyata K.
    Biol Pharm Bull; 2007 Jan 20; 30(1):91-5. PubMed ID: 17202666
    [Abstract] [Full Text] [Related]

  • 4. [Vasopressin receptor antagonists: the vaptans].
    Villabona C.
    Endocrinol Nutr; 2010 May 20; 57 Suppl 2():41-52. PubMed ID: 21130961
    [Abstract] [Full Text] [Related]

  • 5. Management of hyponatremia.
    Goh KP.
    Am Fam Physician; 2004 May 15; 69(10):2387-94. PubMed ID: 15168958
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms, risks, and new treatment options for hyponatremia.
    Ghali JK.
    Cardiology; 2008 May 15; 111(3):147-57. PubMed ID: 18434717
    [Abstract] [Full Text] [Related]

  • 7. Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985.
    Decaux G.
    J Lab Clin Med; 2001 Jul 15; 138(1):18-21. PubMed ID: 11433224
    [Abstract] [Full Text] [Related]

  • 8. Serum and urine responses to the aquaretic agent tolvaptan in hospitalized hyponatremic patients.
    Vaghasiya RP, DeVita MV, Michelis MF.
    Int Urol Nephrol; 2012 Jun 15; 44(3):865-71. PubMed ID: 21607553
    [Abstract] [Full Text] [Related]

  • 9. Management of euvolemic hyponatremia attributed to SIADH in the hospital setting.
    Peri A, Giuliani C.
    Minerva Endocrinol; 2014 Mar 15; 39(1):33-41. PubMed ID: 24513602
    [Abstract] [Full Text] [Related]

  • 10. Cerebral correlates of hyponatremia.
    Nathan BR.
    Neurocrit Care; 2007 Mar 15; 6(1):72-8. PubMed ID: 17356196
    [Abstract] [Full Text] [Related]

  • 11. [Hyponatremia].
    Heinrich S, Wagner A, Gross P.
    Med Klin Intensivmed Notfmed; 2013 Feb 15; 108(1):53-8. PubMed ID: 22948253
    [Abstract] [Full Text] [Related]

  • 12. [Hyponatremia secondary to inappropriate antidiuretic hormone secretion].
    Zamboli P, De Nicola L, Minutolo R, Iodice C, Avino D, Mascia S, D'Angiò P, Calabria M, Conte G.
    G Ital Nefrol; 2008 Feb 15; 25(5):554-61. PubMed ID: 18985840
    [Abstract] [Full Text] [Related]

  • 13. Hyponatremia in the postoperative craniofacial pediatric patient population: a connection to cerebral salt wasting syndrome and management of the disorder.
    Levine JP, Stelnicki E, Weiner HL, Bradley JP, McCarthy JG.
    Plast Reconstr Surg; 2001 Nov 15; 108(6):1501-8. PubMed ID: 11711918
    [Abstract] [Full Text] [Related]

  • 14. Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia.
    Palm C, Pistrosch F, Herbrig K, Gross P.
    Am J Med; 2006 Jul 15; 119(7 Suppl 1):S87-92. PubMed ID: 16843091
    [Abstract] [Full Text] [Related]

  • 15. Vasopressin receptor antagonists.
    Greenberg A, Verbalis JG.
    Kidney Int; 2006 Jun 15; 69(12):2124-30. PubMed ID: 16672911
    [Abstract] [Full Text] [Related]

  • 16. Syndrome of inappropriate antidiuresis without involving inappropriate secretion of vasopressin in an elderly woman: effect of intravenous administration of the nonpeptide vasopressin V2 receptor antagonist OPC-31260.
    Kamoi K.
    Nephron; 1997 Jun 15; 76(1):111-5. PubMed ID: 9171309
    [Abstract] [Full Text] [Related]

  • 17. [Hyponatremic syndrome].
    Urso C, Caimi G.
    Clin Ter; 2012 Jun 15; 163(1):e29-39. PubMed ID: 22362242
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic potential of vasopressin receptor antagonists.
    Ali F, Guglin M, Vaitkevicius P, Ghali JK.
    Drugs; 2007 Jun 15; 67(6):847-58. PubMed ID: 17428103
    [Abstract] [Full Text] [Related]

  • 19. [Hyponatremia : The water-intolerant patient].
    Hensen J.
    Med Klin Intensivmed Notfmed; 2012 Sep 15; 107(6):440-7. PubMed ID: 22911166
    [Abstract] [Full Text] [Related]

  • 20. [Differential diagnosis and treatment of hyponatremia].
    Mydlík M, Derzsiová K, Frank K.
    Vnitr Lek; 2013 Jun 15; 59(6):478-81. PubMed ID: 23808743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 80.